Siemens and BrainLab introduce NaviVision surgical navigation platform:

Siemens Medical Solutions and image-guided therapy developer BrainLAB have introduced a surgical technology platform to allow doctors more room in the operating room and help facilitate workflow. The NaviVision system, due for commercial launch in January 2006, combines Siemens' surgical C-arm with BrainLAB's optical 2D/3D navigation unit. NaviVision is the first integrated optical navigation platform to feature automatic recording for surgery supported by an image receptor, the companies said. The system's navigation can be attached directly to the C-arm's workstation or directly to the OR table. Using a touch screen, the surgeon can easily operate the system's monitor and switch between axial and lateral views. The system was introduced as a "work-in-progress" at last month's annual meeting of the Radiological Society of North America (RSNA).

Siemens Medical Solutions and image-guided therapy developer BrainLAB have introduced a surgical technology platform to allow doctors more room in the operating room and help facilitate workflow. The NaviVision system, due for commercial launch in January 2006, combines Siemens' surgical C-arm with BrainLAB's optical 2D/3D navigation unit. NaviVision is the first integrated optical navigation platform to feature automatic recording for surgery supported by an image receptor, the companies said. The system's navigation can be attached directly to the C-arm's workstation or directly to the OR table. Using a touch screen, the surgeon can easily operate the system's monitor and switch between axial and lateral views. The system was introduced as a "work-in-progress" at last month's annual meeting of the Radiological Society of North America (RSNA).

Welcome to Medtech Insight

Create an account to read this article

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Execs On The Move: July 14–18, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Time For Medtech To Have Its Say On Critical Changes In EU Framework Legislation

 

In revising the foundations of EU product legislation, the European Commission aims to increase harmonization, cut regulatory burdens and promote digital tools to boost compliance and safety.

Medtech M&A Resurges: How To Define Startup Exit Strategy

 

The medtech M&A landscape is experiencing a resurgence fueled by significant capital from private equity and venture firms, says Alex Wakefield, CRO of AcuityMD. Building strong relationships with physicians remains crucial in medtech, and defining an exit strategy early is imperative.